|
|
Reference
|
|
  
|
*** (1970) Urokinase pulmonary embolism trial. Phase 1 results: A cooperative study. JAMA, 214(12): 2163-72
|
|
|
*** (1974) Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study. JAMA, 229(12): 1606-13
|
|
|
*** (1990) Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest, 97(3): 528-33
|
|
2
|
Anderson, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, N.A., Jovanovic, B., Forcier, A., Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med, 151(5): 933-8
|
|
|
Comess, K.A., DeRook, F.A., Russell, M.L., Tognazzi-Evans, T.A., Beach, K.W. (2000) The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity. Am J Med, 109(5): 351-6
|
|
1
|
Dalen, J.E., Alpert, J.S. (1975) Natural history of pulmonary embolism. Prog Cardiovasc Dis, 17(4): 259-70
|
|
|
Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G. (1992) PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 20(3): 520-6
|
|
|
Goldhaber, S.Z., Haire, W.D., Feldstein, M.L., Miller, M., Toltzis, R., Smith, J.L., Taveira, da S.A.M., Come, P.C., Lee, R.T., Parker, J.A. (1993) Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet, 341(8844): 507-11
|
|
4
|
Goldhaber, S.Z., Visani, L., de Rosa, M. (1999) Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 353(9162): 1386-9
|
|
1
|
Goldhaber, S.Z. (2004) Pulmonary embolism. Lancet, 363(9417): 1295-305
|
|
|
Goldhaber, S.Z. (2004) Prevention of recurrent idiopathic venous thromboembolism. Circulation, 110(24 Suppl 1): IV20-4
|
|
2
|
Jerjes-Sanchez, C., Ramirez-Rivera, A., de Lourdes, G.M., Arriaga-Nava, R., Valencia, S., Rosado-Buzzo, A., i dr. (1995) Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis, 2(3), str. 227-9
|
|
 1
|
Kasper, W., Konstantinides, S., Geibel, A., Olschewski, M., Heinrich, F., Grosser, K.D., Rauber, K., Iversen, S., Redecker, M., Kienast, J. (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol, 30(5): 1165-71
|
|
1
|
Konstantinides, S., Geibel, A., Olschewski, M., Heinrich, F., Grosser, K., Rauber, K., Iversen, S., Redecker, M., Kienast, J., Just, H., Kasper, W. (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry. Circulation, 96(3): 882-8
|
|
1
|
Lilienfeld, D.E., Chan, E., Ehland, J., Godbold, J.H., Landrigan, P.J., Marsh, G. (1990) Mortality from pulmonary embolism in the United States: 1962 to 1984. Chest, 98(5): 1067-72
|
|
|
Mandelli, V., Schmid, C., Zogno, C., Morpurgo, M. (1997) 'False negatives' and 'false positives' in acute pulmonary embolism: A clinical-postmortem comparison. Cardiologia, 42(2): 205-10
|
|
|
Meneveau, N., Schiele, F., Metz, D., Valette, B., Attali, P., Vuillemenot, A., Grollier, G., Elaerts, J., Mossard, J.M., Viel, J.F., Bassand, J.P. (1998) Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol, 31(5): 1057-63
|
|
|
Meyer, G., Sors, H., Charbonnier, B., Kasper, W., Bassand, J.P., Kerr, I.H., Lesaffre, E., Vanhove, P., Verstraete, M. (1992) Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 19(2): 239-45
|
|
|
Meyer, G., Gisselbrecht, M., Diehl, J.L., Journois, D., Sors, H. (1998) Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism. Am J Med, 105(6): 472-7
|
|
|
Miller, G.A., Hall, R.J., Paneth, M. (1977) Pulmonary embolectomy, heparin, and streptokinase: Their place in the treatment of acute massive pulmonary embolism. Am Heart J, 93(5): 568-74
|
|
1
|
Morpurgo, M., Schmid, C., Mandelli, V. (1998) Factors influencing the clinical diagnosis of pulmonary embolism: Analysis of 229 postmortem cases. Int J Cardiol, 65 Suppl 1: S79-82
|
|
|
Morrell, M.T., Dunnill, M.S. (1968) The post-mortem incdence of pulmonary embolism in a hospital population. Br J Surg, 55(5): 347-52
|
|
|
Ornstein, D.L., Cushman, M. (2003) Cardiology patient page. Factor V Leiden. Circulation, 107(15): e94-7
|
|
|
Stein, P.D. (1996) The history and physical examination in all patients irrespective of prior cardiopulmonary disease: Pulmonary embolism. Baltimore, itd: Williams and Wilkins
|
|
|
Thames, M.D., Alpert, J.S., Dalen, J.E. (1977) Syncope in patients with pulmonary embolism. JAMA, 238(23): 2509-11
|
|
4
|
Torbitzki, A., van Beek, E.J.R., Charbonnier, B., i dr. (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J, 21(16): 1301-36
|
|
|
Verstraete, M., Miller, G.A., Bounameaux, H., Charbonnier, B., Colle, J.P., Lecorf, G., Marbet, G.A., Mombaerts, P., Olsson, C.G. (1988) Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation, 77(2): 353-60
|
|
|
Wahlander, K., Larson, G., Lindahl, T.L., Andersson, C., Frison, L., Gustafsson, D., Bylock, A., Eriksson, B.I. (2002) Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost, 87(4): 580-5
|
|
|
Wong, G.S., Murphy, J.G. (2000) Thrombolytic trials for acute myocaridal infarction. u: Murphy J.G. (ur.) Mayo Clinic cardiology review, Philadelphia: Lippincott Williams and Wilkins, str. 175-84
|
|
1
|
Wood, K.E. (2002) Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest, 121(3): 877-905
|
|
|
Yakovlev, V.B., Yakovleva, M.V. (2004) Pulmonary artery thromboembolism. Kardiologia, 40(1), str. 75-82.(Russian)
|
|
|
|
|